FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W202637265> ?p ?o ?g. }

• W202637265 endingPage "113" @default.
• W202637265 startingPage "101" @default.
• W202637265 abstract "Understanding the nature of neutralization may provide information for crafting improvements in HIV vaccines. Using JR-FL as a prototype primary pseudovirus, we first investigated anti-HIV monoclonal antibodies (mAbs) in several neutralization formats designed to elucidate the timing of neutralization. MAb b12 was most effective before receptor binding, 2G12 neutralized effectively even after CD4 binding, and X5 and a V3 loop mAb (LE311) were inactive in a standard format but were induced by sCD4. Consistent with this latter finding, native PAGE indicated that X5 and V3 mAb binding to Envelope trimers was dependent on sCD4 binding. In contrast, 2F5 and 4E10 were active even post-CD4/CCR5 engagement. We next analyzed the neutralization mechanism of a panel of HIV+ donor plasmas of various potencies. All mediated high levels of post-CD4 neutralization that was not associated with activity in the standard format. None, however, neutralized effectively in the post-CD4/CCR5 format, suggesting that 2F5/4E10-like Abs were absent or at low concentrations. Finally, we analyzed a non-neutralizing plasma spiked with mAbs b12, 2G12 or 2F5, which resulted in increases in neutralization titers consistent with the activities of the mAbs. We conclude that these methods, together with other mapping approaches, may provide a better understanding of neutralization that could be useful in vaccine research." @default.
• W202637265 created "2016-06-24" @default.
• W202637265 creator A5023994515 @default.
• W202637265 creator A5024405434 @default.
• W202637265 creator A5030822254 @default.
• W202637265 creator A5036226478 @default.
• W202637265 creator A5054567155 @default.
• W202637265 creator A5067275151 @default.
• W202637265 creator A5068966647 @default.
• W202637265 creator A5073322790 @default.
• W202637265 date "2006-05-09" @default.
• W202637265 modified "2023-09-23" @default.
• W202637265 title "Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization" @default.
• W202637265 cites W1512910131 @default.
• W202637265 cites W1635348995 @default.
• W202637265 cites W1753511464 @default.
• W202637265 cites W1917537139 @default.
• W202637265 cites W1938402363 @default.
• W202637265 cites W1964684801 @default.
• W202637265 cites W1966092083 @default.
• W202637265 cites W1967972208 @default.
• W202637265 cites W1971777539 @default.
• W202637265 cites W1990407513 @default.
• W202637265 cites W1993607543 @default.
• W202637265 cites W1994030446 @default.
• W202637265 cites W1994322627 @default.
• W202637265 cites W1994609426 @default.
• W202637265 cites W1998987175 @default.
• W202637265 cites W1999053028 @default.
• W202637265 cites W2004200027 @default.
• W202637265 cites W2010491479 @default.
• W202637265 cites W2011206581 @default.
• W202637265 cites W2012451048 @default.
• W202637265 cites W2017551575 @default.
• W202637265 cites W2033669661 @default.
• W202637265 cites W2034160159 @default.
• W202637265 cites W2044465251 @default.
• W202637265 cites W2048336729 @default.
• W202637265 cites W2054399251 @default.
• W202637265 cites W2070701468 @default.
• W202637265 cites W2083094268 @default.
• W202637265 cites W2083803997 @default.
• W202637265 cites W2090763940 @default.
• W202637265 cites W2093282128 @default.
• W202637265 cites W2096966517 @default.
• W202637265 cites W2097594050 @default.
• W202637265 cites W2099308199 @default.
• W202637265 cites W2099576234 @default.
• W202637265 cites W2099749788 @default.
• W202637265 cites W2102548388 @default.
• W202637265 cites W2105364254 @default.
• W202637265 cites W2108304375 @default.
• W202637265 cites W2110679986 @default.
• W202637265 cites W2110917275 @default.
• W202637265 cites W2116983636 @default.
• W202637265 cites W2126977955 @default.
• W202637265 cites W2128461524 @default.
• W202637265 cites W2129274180 @default.
• W202637265 cites W2131039822 @default.
• W202637265 cites W2132424521 @default.
• W202637265 cites W2141444589 @default.
• W202637265 cites W2146704167 @default.
• W202637265 cites W2150001263 @default.
• W202637265 cites W2150412330 @default.
• W202637265 cites W2156720884 @default.
• W202637265 cites W2157210912 @default.
• W202637265 cites W2157272520 @default.
• W202637265 cites W2158181429 @default.
• W202637265 cites W2160180163 @default.
• W202637265 cites W2162071888 @default.
• W202637265 cites W2162546635 @default.
• W202637265 cites W2163558461 @default.
• W202637265 cites W2168021894 @default.
• W202637265 cites W2168725710 @default.
• W202637265 cites W2168869784 @default.
• W202637265 cites W2169367715 @default.
• W202637265 cites W2171790647 @default.
• W202637265 cites W2172063653 @default.
• W202637265 cites W2439249638 @default.
• W202637265 doi "https://doi.org/10.3233/hab-2005-143-407" @default.
• W202637265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2630880" @default.
• W202637265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16720980" @default.
• W202637265 hasPublicationYear "2006" @default.
• W202637265 type Work @default.
• W202637265 sameAs 202637265 @default.
• W202637265 citedByCount "51" @default.
• W202637265 countsByYear W2026372652012 @default.
• W202637265 countsByYear W2026372652013 @default.
• W202637265 countsByYear W2026372652014 @default.
• W202637265 countsByYear W2026372652015 @default.
• W202637265 countsByYear W2026372652016 @default.
• W202637265 countsByYear W2026372652017 @default.
• W202637265 countsByYear W2026372652018 @default.
• W202637265 countsByYear W2026372652021 @default.
• W202637265 countsByYear W2026372652023 @default.
• W202637265 crossrefType "journal-article" @default.
• W202637265 hasAuthorship W202637265A5023994515 @default.
• W202637265 hasAuthorship W202637265A5024405434 @default.

• next